These success, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of targeting ACKR3 as a singular method to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Diseases.May support alleviate nerve suffering an